System | Type | Disorder | Pubmed |
cancer | | | |
considered as a potential therapeutic target for cancers |
cancer | reproductive | breast | |
attractive targets for improvements in breast cancer therapy |
cancer | digestive | oesophagus | |
is a potential therapeutic target for ESCC patients, even those in an advanced stage |
cancer | head and neck | | |
MELK inhibition may also be promising for clinical applications in the treatment of HNSCC |
cancer | brain | glioma/neuroblstoma | |
is a novel therapeutic target for NB and its inhibitor OTSSP167 is a promising drug for further clinical development |
cancer | | | |
MELK inhibition may be effective for human cancers even if TP53 is mutated |
immunology | infectious | | |
potential target for anti-HIV therapy |
cancer | digestive | liver | |
promising molecular target to develop therapeutic strategies for patients with advanced HCC |